Mallard J, Debrut L, Hucteau E, Somme L, Bischoff H, Moinard-Butot F, Coliat P, Bendjama A, Weltzer L, Sharifi Tafreshi A, Billand C, Charlot A, Boutonnet L, Laverny G, Keime C, Favret F, Schott R, Pivot X, Hureau TJ, Pagano AF

Am J Physiol Cell Physiol. 2026 04 16;:

Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination.

Len-Tayon K, Gantzer J, Dariane C, Fogel O, Friedrich V, Rovito D, Lindner V, Gilbart V, Yanushko D, Henri S, Metzger D, Laverny G

EMBO Mol Med. 2026 04 10;:

New insights into prostate cancer progression: A focus on vitamin D signaling.

Friedrich V, Laverny G

J Steroid Biochem Mol Biol. 2026 04 8;261:107019

HIF1 inhibition targets tumoral and myeloid cells, and is a promising therapy for metastatic castration-resistant prostate cancer.

Yanushko D, Pichot A, Vincent A, Keime C, Laverny G, Metzger D

Cell Death Dis. 2026 03 27;:

Single-cell analysis reveals that the hormone T3 affects colon epithelial differentiation and induces a mixed progenitor-like cell population.

Bidoli C, Reslinger M, Sieffert C, Weis B, Laverny G, Gerdol M, Plateroti M

Sci Rep. 2026 02 24;:

Targeting pre-existing club-like cells in prostate cancer potentiates androgen deprivation therapy.

Baurès M, Vieira Aleixo AS, Pacreau E, Koshy A, Friedrich V, Diedisheim M, Raigel M, Hua Y, Dariane C, Boutillon F, Kenner L, Marine JC, Laverny G, Metzger D, Rambow F, Guidotti JE, Goffin V

EMBO Mol Med. 2026 02 2;:

Characterization of the immune landscape in healthy mouse prostate and during prostate cancer progression.

Pervizou D, De Chiara J, Spinelli L, Nestor-Martin M, Chasson L, Len-Tayon K, Yanushko D, Fiore F, Bajénoff M, Malissen B, Metzger D, Laverny G, Henri S

Oncoimmunology. 2025 12;14(1):2562220

Enhanced proteasome activity in perifascicular myofibres is a hallmark of dermatomyositis and its inhibition is efficient in preclinical models.

Debrut L, Giannini M, Quiring G, Perniola S, Rovito D, Keime C, Lannes B, Nadaj-Pakleza A, Chanson JB, Charles AL, Geny B, Metzger D, Laverny G, Meyer A

Ann Rheum Dis. 2025 10 6;:

Experimental myositis: an optimised version of C-protein-induced myositis.

Giannini M, Rovito D, Oulad-Abdelghani M, Messaddeq N, Debrut L, Quiring G, Kessler P, Charles AL, Geny B, Metzger D, Laverny G, Meyer A

RMD Open. 2025 03 5;11(1):

[New insights of vitamin D-based therapy for prostate cancer].

Len-Tayon K, Metzger D, Laverny G

Med Sci (Paris). 2025 02;41(2):154-159

p53-loss induced prostatic epithelial cell plasticity and invasion is driven by a crosstalk with the tumor microenvironment.

Yanushko D, German Falcon B, El Bizri R, Pervizou D, Dolgos R, Keime C, Ye T, Thibault-Carpentier C, Le Magnen C, Henri S, Laverny G, Metzger D

Cell Death Dis. 2025 01 26;16(1):46

A vitamin D-based strategy overcomes chemoresistance in prostate cancer.

Len-Tayon K, Beraud C, Fauveau C, Belorusova AY, Chebaro Y, Mouriño A, Massfelder T, Chauchereau A, Metzger D, Rochel N, Laverny G

Br J Pharmacol. 2024 07 9;:

4-Hydroxy-1α,25-Dihydroxyvitamin D: Synthesis and Structure-Function Study.

Peluso-Iltis C, Pierrat N, Rovito D, Osz J, Sawada D, Kittaka A, Laverny G, Rochel N

Biomolecules. 2024 05 3;14(5):

LSD1 inhibition circumvents glucocorticoid-induced muscle wasting of male mice.

Cai Q, Sahu R, Ueberschlag-Pitiot V, Souali-Crespo S, Charvet C, Silem I, Cottard F, Ye T, Taleb F, Metzger E, Schuele R, Billas IML, Laverny G, Metzger D, Duteil D

Nat Commun. 2024 04 26;15(1):3563

Targeting Mitochondrial Dynamics during Lower-Limb Ischemia Reperfusion in Young and Old Mice: Effect of Mitochondrial Fission Inhibitor-1 (mDivi-1).

Paradis S, Charles AL, Giannini M, Meyer A, Lejay A, Talha S, Laverny G, Charloux A, Geny B

Int J Mol Sci. 2024 04 4;25(7):

Title: Sarcopenia assessed by DXA and hand-grip dynamometer: a potential marker of damage, disability and myokines imbalance in inflammatory myopathies.

Giannini M, Charles AL, Evrard C, Blaess J, Bouchard-Marmen M, Debrut L, Perniola S, Laverny G, Javier RM, Charloux A, Geny B, Meyer A

Rheumatology (Oxford). 2024 03 27;:

Mouse Models of Mineral Bone Disorders Associated with Chronic Kidney Disease.

Zaloszyc A, Bernardor J, Bacchetta J, Laverny G, Schmitt CP

Int J Mol Sci. 2023 03 10;24(6):

Vitamin D Analogs Bearing C-20 Modifications Stabilize the Agonistic Conformation of Non-Responsive Vitamin D Receptor Variants.

Belorusova AY, Rovito D, Chebaro Y, Doms S, Verlinden L, Verstuyf A, Metzger D, Rochel N, Laverny G

Int J Mol Sci. 2022 07 30;23(15):

Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression.

Abu El Maaty MA, Terzic J, Keime C, Rovito D, Lutzing R, Yanushko D, Parisotto M, Grelet E, Namer IJ, Lindner V, Laverny G, Metzger D

Sci Adv. 2022 07 22;8(29):eabo2295

Vitamin D and calcium intakes in general pediatric populations: A French expert consensus paper.

Bacchetta J, Edouard T, Laverny G, Bernardor J, Bertholet-Thomas A, Castanet M, Garnier C, Gennero I, Harambat J, Lapillonne A, Molin A, Naud C, Salles JP, Laborie S, Tounian P, Linglart A

Arch Pediatr. 2022 Mar 16;:

Design, Synthesis, Evaluation and Structure of Allenic 1a,25- Dihydroxyvitamin D3 Analogs with Locked Mobility at C-17.

Mourino A, Fraga R, Len K, Lutzing G, Laverny G, Loureiro J, Maestro M, Rochel N, Rodriguez-Borges JE

Chemistry. 2021 Jul 5;:

Single-cell analyses unravel cell type-specific responses to a vitamin D analog in prostatic precancerous lesions.

Abu El Maaty MA, Grelet E, Keime C, Rerra AI, Gantzer J, Emprou C, Terzic J, Lutzing R, Bornert JM, Laverny G, Metzger D

Sci Adv. 2021 Jul;7(31):

Myod1 and GR coordinate myofiber-specific transcriptional enhancers.

Rovito D, Rerra AI, Ueberschlag-Pitiot V, Joshi S, Karasu N, Dacleu-Siewe V, Rayana KB, Ghaibour K, Parisotto M, Ferry A, Jelinsky SA, Laverny G, Klaholz BP, Sexton T, Billas IML, Duteil D, Metzger D

Nucleic Acids Res. 2021 Apr 9;:

Cytosolic sequestration of the vitamin D receptor as a therapeutic option for vitamin D-induced hypercalcemia.

Rovito D, Belorusova AY, Chalhoub S, Rerra AI, Guiot E, Molin A, Linglart A, Rochel N, Laverny G, Metzger D

Nat Commun. 2020 12 7;11(1):6249

Aging Exacerbates Ischemia-Reperfusion-Induced Mitochondrial Respiration Impairment in Skeletal Muscle.

Paradis S, Charles AL, Georg I, Goupilleau F, Meyer A, Kindo M, Laverny G, Metzger D, Geny B

Antioxidants (Basel). 2019 Jun 8;8(6):

PGC-1β modulates statin-associated myotoxicity in mice.

Singh F, Zoll J, Duthaler U, Charles AL, Panajatovic MV, Laverny G, McWilliams TG, Metzger D, Geny B, Krähenbühl S, Bouitbir J

Arch. Toxicol.. 2018 Dec 3;:

Diabetes Worsens Skeletal Muscle Mitochondrial Function, Oxidative Stress, and Apoptosis After Lower-Limb Ischemia-Reperfusion: Implication of the RISK and SAFE Pathways?

Pottecher J, Adamopoulos C, Lejay A, Bouitbir J, Charles AL, Meyer A, Singer M, Wolff V, Diemunsch P, Laverny G, Metzger D, Geny B

Front Physiol. 2018 ;9:579

Mitochondria: An Organelle of Bacterial Origin Controlling Inflammation.

Meyer A, Laverny G, Bernardi L, Charles AL, Alsaleh G, Pottecher J, Sibilia J, Geny B

Front Immunol. 2018 ;9:536

Conditional expression of Ki-Ras(G12V) in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma.

Andò S, Malivindi R, Catalano S, Rizza P, Barone I, Panza S, Rovito D, Emprou C, Bornert JM, Laverny G, Metzger D

Oncogene. 2017 Jul;:

IFN-β-induced reactive oxygen species and mitochondrial damage contribute to muscle impairment and inflammation maintenance in dermatomyositis.

Meyer A, Laverny G, Allenbach Y, Grelet E, Ueberschlag V, Echaniz-Laguna A, Lannes B, Alsaleh G, Charles AL, Singh F, Zoll J, Lonsdorfer E, Maurier F, Boyer O, Gottenberg JE, Nicot AS, Laporte J, Benveniste O, Metzger D, Sibilia J, Geny B

Acta Neuropathol.. 2017 Jun;: